Pharmaceutical News
-
Business
U.S. FDA Raises Seven Observations at Dr. Reddy’s Hyderabad Biologics Facility
The U.S. FDA has issued seven Form 483 observations after inspecting Dr. Reddy’s biologics facility in Hyderabad. Read the latest…
Read More »